Vascular Therapies Is A Biotechnology Company Dedicated To Enhancing Patient Outcomes By Addressing Surgical Stenosis In Individuals With Kidney And Vascular Diseasesfounded In 2001 By Sriram Iyerthe Company Focuses On The Clinical Challenge Of Surgical Anastomotic Intimal Hyperplasiacentral To Its Mission Is The Development Of Sirogen Tma Proprietary Sirolimus Formulation Aimed At Localperivascular Drug Delivery To Improve Vascular Access During Hemodialysis Under The Leadership Of Ceo John Mcdermottwho Has Extensive Experience In The Vascular Industryvascular Therapies Has Conducted A Phase 3 Clinical Trial Called Access 1This Trial Evaluated The Safety And Effectiveness Of Sirogen Tm In Patients With End Stage Renal Disease And Chronic Kidney Diseaseyielding Positive Resultsthe Company Is Now Planning A Follow Up Trialaccess 2To Further Validate These Findingsvascular Therapies Collaborates With Healthcare Professionals To Ensure The Effectiveness Of Its Treatments For Patients Requiring Hemodialysis
No conferences found for this company.
| Company Name | Vascular Therapies Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
